Samantha M. Thomas, MS

Principal Biostatistician
Duke Cancer Institute

Poster(s):

• E14: Germline Genetic Testing for Patients with Breast Atypia

• E16: Differences in Rates of Pathological Complete Response and Overall Survival in Patients with Triple Negative Breast Cancer Based on HER2 Status and Race/Ethnicity

• E17: Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy

• E245: Determining risks of false negative nodal staging in pancreatic cancer following neoadjuvant therapy and surgery

• E58: Staging for de novo Metastatic Breast Cancer: Can genomic data make it better?

• E7: Multi-Institution Review of Contralateral Axillary Metastases: Time for Reclassification as a Local-Regional Event?

• P6: Comparison of Survival Outcomes for Select Patients with Stage III vs Stage IV Disease